SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Stuart Scott’s 30 for 30 brought back a lot of hard memories
I never met Stuart Scott. I really wish I had. He hit ESPN at just the right time. I had just started high school when...
Sun Dec 28, 2025

Odd happenings on UNC’s campus in 2025
Tyler Hansbrough, a star UNC basketball player from 2005 to 2009, made a surprising resurgence in Carolina culture this year. Hansbrough co-taught a sports communication...
Sun Dec 28, 2025

Surplus Sid's has closed in Carrboro. What's next for its owner, Barry Keith.
Barry Keith may be the "Emperor of Carrboro" - but to the people who know him, he's just "Sid." Keith, 70, hung up the...
Fri Dec 26, 2025

UNC student creates new way to rank NBA coaches
Win-loss records and championship rings usually define the best NBA coaches, but UNC-Chapel Hill student Shane Faberman looked at different data to see which coaches...
Thu Dec 25, 2025